Circulating Cytomegalovirus (CMV)-Infected Endothelial Cells in Patients with an Active CMV Infection

Journal of Infectious Diseases

Volumn 167, Issue 2, 1993, Pages 270-277

  Grefte, Annemarie ^a   Giessen, Marijke van der ^a   Son, Willem van ^a   The, T Hauw ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; MONOCLONAL ANTIBODY; VIRUS ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BLOOD; BLOOD VESSEL INJURY; CELL ADHESION; CELL DIFFERENTIATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPEROXIDASE STAINING; PRIORITY JOURNAL; VIRUS INCLUSION; VIRUS REPLICATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; BIOPSY; CONNECTIVE TISSUE DISEASES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENDOTHELIUM, VASCULAR; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOCOMPROMISED HOST; IMMUNOENZYME TECHNIQUES; INCLUSION BODIES, VIRAL; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME;

EID: 0027391502     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/167.2.270     Document Type: Article

References (60)

1. Rubin RH. Infections in the patient after renal and liver transplantation. In: Rubin RH. Young LS. eds. Clinical approach to infections in the immunocompromised host. 2nd ed. New York: Plenum Press. 1988:557-83.
2. van Son WJ, The TH. Cytomegalovirus infection after organ transplantation: An update with special emphasis on renal transplantation. Transpl Int 1989;2: 147-64.
3. Jesionek A, Kiolemenoglou B. Uber einen Befund von protozoen-artigen gebilden in den Organen eines hereditair-Iuetischen Foetus. Munch Med Wochenschr 1904;51:1905-7.
4. Francis ND. Boylston AW. Roberts AHG. Parkin JM. Pinching AJ. Cytomegalovirus infection in gastrointestinal tracts of patients infected with HIV-I or AIDS. J Clin PathoL 1989;42:1055-64.
5. Foucar E, Mukai K, Foucar K, Sutherland DER, van Buren CT. Colon ulceration in lethal cytomegalovirus infection. Am J C1in Pathol 1981;76:788-801.
6. Min KW. Wickemeyer WJ. Chandran P. et al. Fatal cytomegalovirus infection and coronary arterial thromboses after heart transplantation: A case report. J Heart Transplant 1987;6: 100-5.
7. Bournerias I, Boisnic S, Patey O. et al. Unusual cutaneous cytomegalovirus involvement in patients with acquired immunodeficiency syndrome. Arch Dermatol 1989; 125:1243-6.
8. Myerson D. Hackman RC, Nelson JA. Ward DC, McDougall JK. Widespread presence of histologically occult cytomegalovirus. Hum Pathol 1984; 15:430-9.
9. Burke G. Nichols L Balogh K. et al. Perforation of the terminal ileum with cytomegalovirus vasculitis and Kaposi's sarcoma in a patient with acquired immunodeficiency syndrome. Surgery 1987; 102: 540-5.
10. Aukrust P, Moum B, Farstad IN, Holter E, Bjorneklett A, Kremer D. Fatal cytomegalovirus (CMV) colitis in a patient receiving low dose prednisolone therapy. Scand J Infect Dis 1991;23:495-9.
11. Hirose Y, Imaoka T, Konda S, Ultrastructural observations on the cytomegalic inclusion cell in peripheral blood. Hum Pathol 1988; 19: 95-8.
12. Carney WP. Hirsch MS. Mechanisms of immunosuppression in cytomegalovirus mononucleosis. II. Virus-monocyte interactions. J Infect Dis 1981;144:47-54.
13. Rinaldo CR, Black PH, Hirsch MS. Interaction of cytomegalovirus with leukocytes from patients with mononucleosis due to cytomegalovirus. J Infect Dis 1977;136:667-78.
14. Saltzman RL, Quirk MR, Jordan ME. Disseminated cytomegalovirus infection: Molecular analysis of virus and leukocyte interactions in viremia. J Clin Invest 1988;81: 75-81.
15. Schrier RD. Nelson JA. Oldstone MBA. Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science 1985;230: 1048-51.
16. Jiwa NM, van Gernert GW, Raap AK. et al. Rapid detection ofhuman cytomegalovirus DNA in peripheral blood leukocytes of viremic transplant recipients by the polymerase chain reaction. Transplantation 1989;48:72-6.
17. Dankner WM, McCutchan JA, Richman DD, Hirata K, Spector SA. Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization. J Infect Dis 1990; 161:31-6.
18. Rice GPA, Schrier RD, Oldstone MBA. Cytomegalovirus infects human lymphocytes and monocytes: Virus expression is restricted to immediate early antigen products. Proc Natl Acad Sci USA 1984;81:6134-8.
19. van der Bij W. Torensma R. van Son WJ, et al. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leukocytes. J Med Virol 1988;25: 179-88.
20. van der Bij W, Schirm J, Torensma R, van Son WJ, Tegzess AM, The TH. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J C1in Microbiol 1988;26:2531-5.
21. Grefte JMM, van der Gun BTF, Schmolke S. et al. The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active HCMV infection. J Gen Virol 1992;73:2923-32.
22. van den Berg AP. van der Bij W. van Son WJ, et al. Cytomegalovirusantigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation: A report of 130 consecutive patients. Transplantation 1989;48:991-5.
23. van den Berg AP, Klompmaker JJ, Haagsma EB. et al. Antigenemia in the diagnosis and monitoring of active cytomegalovirus infection after liver transplantation. J Infect Dis 1991;164:265-70.
24. Jaffe EA, Nachman RL. Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2745-56.
25. Maciag T, Cerundolo J, Ilsley S, Kelley PR, Forand R. An endothelial cell growth factor from bovine hypothalamus: Identification and partial characterization. Proc Natl Acad Sci USA 1979;76:5674-8.
26. Middeldorp JM, Jongsma J. The TH. Detection ofimmunoglobulin M and G antibodies against cytomegalovirus early and late antigens by enzyme-linked immunosorbent assay. J C1in Microbiol 1984; 20:763-71.
27. Middeldorp JM, Jongsma J, The TH. Killing of human cytomegalovirus-infected fibroblasts by antiviral antibody and complement. J Infect Dis 1986;153:48-55.
28. Li CY, Lam KW, Yam LT. Esterases in human leukocytes. J Histochem Cytochem 1973;21: 1-12.
29. Mazeron MC, Jahn G, Plachter B. Monoclonal antibody E-13 (McAb 810) to human cytomegalovirus recognizes an antigen encoded by exon 2 of the major immediate-early gene. J Gen Virol 1992;73:2699-703.
30. Plachter B, Nordin M, Zweygberg Wirgart B. et al. The DNA-binding protein p52 of human cytomegalovirus reacts with monoclonal antibody CCH2 and associates with the nuclear membrane at late times after infection. Virus Res 1992;24:265-76.
31. Landini MP. Severi B. Furlini G. Badiali De Giorgi L. Human cytomegalovirus structural components: Intracellular and intraviral localization of p28 and p65-69 by immunoelectron microscopy. Virus Res 1987;8: 15-23.
32. Shuster EA. Beneke JS. Tegtmeier GE, et al. Monoclonal antibodies for rapid laboratory detection of cytomegalovirus infections: Characterization and diagnostic application. Mayo Clin Proc 1985;60:577-85.
33. Weiner D, Gibson W, Fields KL. Anti-complement immunofluorescence establishes nuclear localization ofhuman cytomegalovirus matrix protein. Virology 1985; 147:19-28.
34. Cranage MP, Smith GL, Bell SE. et al. Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product. varicella-zoster virus gpIII. and herpes simplex virus type I glycoprotein H. J Virol 1988;62: 1416-22.
35. van der Voort LHM, de Leij LFMH. The TH. Characterization ofmembrane antigens on human cytomegalovirus-infected fibroblasts recognized by human antibodies. J Virol 1989;63: 1485-8.
36. Rudolph SA, Kuhn JE, Korn K. Braun RW, Jahn G. Prokaryotic expression of the major capsid protein of human cytomegalovirus and antigenic cross-reactions with herpes simplex virus type I. J Gen Virol 1990;71:2023-31.
37. Knapp W, Dorken B, Rieber EP, et al., eds. Leukocyte typing IV. White cell differentiation antigens. Oxford. UK: Oxford University Press. 1989.
38. Brandtzaeg P, Jones DB, Flavell OJ, Fagerhol MK. Mac 387 antibody and detection of formalin resistant myelomonocytic LI antigen. J C1in Pathol 1988;41:963-70.
39. Schlingemann RO, Oingjan GM, Emeis JJ, Blok J, Warnaar SO, Ruiter OJ. Monoclonal antibody PAL-E specific for endothelium. Lab Invest 1985;52:71-6.
40. Holthofer H, Virtanen I, Kariniemi AL, Hormia M, Linder E, Miettinen A. Vlex europaeus I lectin as a marker for vascular endothelium in human tissues. Lab Invest 1982;47:60-6.
41. Sharbati R, de Boer M, Marzilli M, Scarlattini M, Rossi G, van Mourik JA. Immunologic detection of endothelial cells in human whole blood. Blood 1991;77:764-9.
42. Alles JU, Bosslet K. Immunohistochemical and immunochemical characterization of a new endothelial cell-specific antigen. J Histochem Cytochem 1986;34:209-14.
43. Downey GP, Doherty DE, Schwab B III, Elson EL, Henson PM, Worthen GS. Retention of leukocytes in capillaries: Role of cell size and deformability. J Appl Physiol 1990;69: 1767-78.
44. Pande H, Terramani T, Tressel T, Churchill MA, Hawkins GG, Zaia JA. Altered expression offibronectin gene in cells infected with human cytomegalovirus. J Virol 1990;64: 1366-9.
45. Bruggeman CA, Debie WHM, Muller AD, Schutte B, van Dam-Mieras MCE. Cytomegalovirus alters the von Willebrand factor content in human endothelial cells. Thromb Haemost 1988;59:264-8.
46. van Dorp WT, Jonges E, Bruggeman CA, Daha MR, van Es LA, van der Woude FJ. Direct induction of MHC class I, but not class II, expression on endothelial cells by cytomegalovirus infection. Transplantation 1989;48:469-72.
47. Grundy JE, Ayles HM, McKeating JA, Butcher RG, Griffiths PO, Poulter LW. Enhancement of class I HLA expression by cytomegalovirus. J Med Virol 1988;25:483-95.
48. van Bruggen I, Price P, Robertson TA, Papadimitriou JM. Morphological and functional changes during cytomegalovirus replication in murine macrophages. J Leukoc Bioi 1989;46:508-20.
49. Smiley ML, Mar ES, Huang ES. Cytomegalovirus infection and viralinduced transformation of human endothelial cells. J Med Virol 1988;25:213-26.
50. Waldman WJ, Sneddon JM, Stephens RE, Roberts WHo Enhanced endothelial cytopathogenicity induced by a cytomegalovirus strain propagated in endothelial cells. J Med Virol 1989;28:223-30.
51. Bouvier CA, Gaynor E, Cintron JR, Bernhardt B, Spaet TH. Circulating endothelium as an indication of vascular injury. Thromb Diath Haemorrh Suppl 1970;40: 163-8.
52. Hladovec J, Prerovsky I, Stanek V, Fabian J. Circulating endothelial cells in acute myocardial infarction and angina pectoris. KIin Wochenschr 1978;56: 1033-6.
53. Valaitis J, McGrew EA, McGrath RG, Roberts SS. Capillary cell clusters in peripheral blood of postoperative cancer and noncancer patients. Acta Cytol 1968; 12:439-44.
54. Herbeuval H, Fourot M, Hettich C, Herbeuval R. Endothelial cells and circulating blood clumps: Differential diagnosis. Acta Cytol 1965;9:68-72.
55. Weigland DA, Burgdorf WHC, Tarpay MM. Vasculitis in cytomegalovirus infection. Arch Dermatol 1980; 116: 1174-6.
56. Petrie BL, Adam E, Melnick JL. Association of herpesvirus/cytomegalovirus infections with human atherosclerosis. Prog Med Virol 1988;35:21-42.
57. Bruggeman CA, van Dam-Mieras MCE. The possible roleofcytomegalovirus in atherogenesis. Prog Med Virol 1991;38:1-26.
58. Ross R, Glomset JA. The pathogenesis of atherosclerosis. N Engl J Med 1976;295:369-77.
59. Ross R. The pathogenesis ofatherosclerosis. An update. N Engl J Med 1986;314:488-500.
60. Visser MR, Vercellotti GM, McCarthy JB, et al. Herpes simplex virus inhibits endothelial cell attachment and migration to extracellular matrix proteins. Am J Pathol 1989;134:223-30.